First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

dc.contributor.authorAarnio E.
dc.contributor.authorHuupponen R.
dc.contributor.authorMartikainen J.
dc.contributor.authorKorhonen M.
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.contributor.organization-code2607100
dc.converis.publication-id41657125
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/41657125
dc.date.accessioned2025-08-28T00:57:34Z
dc.date.available2025-08-28T00:57:34Z
dc.description.abstract<p>Background: Since 1994, the Finnish Prescription Register (FPR) has been the main data source for pharmacoepidemiology research in Finland. However, the FPR data are limited to reimbursed dispensations only. Implementation of electronic prescribing started in 2010 and after a stepwise extension, electronic prescribing became mandatory in all healthcare settings in 2017. Prescriptions issued and dispensed electronically are stored in the Prescription Centre of the nationwide Kanta database.<br /><br />Objectives: To describe the contents of the Kanta database and to compare the coverage of Kanta with the FPR, using prescriptions and dispensations of oral anticoagulants (OACs) as an example.<br /><br />Methods: All prescriptions, dispensations, and their cancellations and corrections for OACs recorded in Kanta were retrieved for the period 2012–2016.<br /><br />Results: In 2016, the total number of valid electronic prescriptions for OACs was 249 139 and the number of valid electronic OAC dispensations was 765 745. The number of identified direct oral anticoagulant (DOAC) users was higher in Kanta compared to the FPR since 2014, although more users of all OACs were identified from the FPR during 2012–2015. In 2016, an indication was identified in 44.7% of OAC prescriptions and dosing instructions in 99.5% of DOAC prescriptions.<br /><br />Conclusions: The Kanta database is a promising source of data on medication exposure. Because of reimbursement restrictions, use of DOACs was under-ascertained through the FPR.<br /></p>
dc.format.pagerange553
dc.format.pagerange559
dc.identifier.jour-issn1551-7411
dc.identifier.olddbid206762
dc.identifier.oldhandle10024/189789
dc.identifier.urihttps://www.utupub.fi/handle/11111/48729
dc.identifier.urnURN:NBN:fi-fe2021042824764
dc.language.isoen
dc.okm.affiliatedauthorAarnio, Emma
dc.okm.affiliatedauthorHuupponen, Risto
dc.okm.affiliatedauthorKorhonen, Maarit
dc.okm.discipline317 Pharmacyen_GB
dc.okm.discipline317 Farmasiafi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherElsevier Inc.
dc.publisher.countryNetherlandsen_GB
dc.publisher.countryAlankomaatfi_FI
dc.publisher.country-codeNL
dc.relation.doi10.1016/j.sapharm.2019.06.012
dc.relation.ispartofjournalResearch in Social and Administrative Pharmacy
dc.relation.volume16
dc.source.identifierhttps://www.utupub.fi/handle/10024/189789
dc.titleFirst insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Revised manuscript.pdf
Size:
489.34 KB
Format:
Adobe Portable Document Format
Description:
Final draft